Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04531046
Title Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Lymphoma Academic Research Organisation
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | BEL

Facility Status City State Zip Country Details
CH Liège Liège 4000 Belgium Details
CHU de Bordeaux - Hôpital Haut Lévêque Bordeaux France Details
CHU Clermont Ferrand - Hôpital Estaing Clermont-Ferrand France Details
APHP - Hôpital Henri Mondor Créteil France Details
CHU de Dijon - Hôpital le Bocage Dijon 21000 France Details
Hôpital Claude Huriez Lille 59037 France Details
Hôpital Saint Eloi Montpellier 34295 France Details
CHU de Nantes - Hôtel Dieu Nantes 44093 France Details
APHP - Hôpital Saint Louis Paris Cedex 10 75475 France Details
Hopital La Pitié Salpétriere Paris France Details
Hôpital Saint Antoine Paris France Details
Centre Hospitalier Lyon Sud Pierre Bénite 69495 France Details
CHU de Rennes - Hôpital de Pontchaillou Rennes 35003 France Details
IUCT Oncopole Toulouse France Details
CHU Brabois Vandoeuvre les Nancy 54511 France Details
Institut de Cancérologie Gustave Roussy Villejuif France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field